Description: Omni Bridgeway Limited engages in investing in litigation funding in Australia, the United States, Canada, Asia, Europe, the Middle East, and Africa. Its practice areas include commercial litigation, finance for corporates, funding for insolvency, class actions, arbitration, and investor recoveries. The company offers services, such as funding for litigations; factual investigations preliminary to litigations; appeal funding; payment of adverse costs orders; strategic planning, monitoring, and managing of litigation; and assistance in facilitating settlements and maximizing the value of claim. The company was formerly known as IMF Bentham Limited and changed its name to Omni Bridgeway Limited in March 2020. Omni Bridgeway Limited was founded in 1986 and is based in Amsterdam, the Netherlands.
Home Page: www.omnibridgeway.com
OBL Technical Analysis
35 Clarence Street
Sydney,
NSW
2000
Australia
Phone:
61 2 8223 3567
Officers
| Name | Title |
|---|---|
| Mr. Andrew Saker | MD, CEO, Chief Strategy Officer - US & Director |
| Mr. Jeremy Thomas Sambrook | Group Gen. Counsel & Company Sec. |
| Mr. Raymond van Hulst | MD & Chief Investment Officer of EMEA and Exec. Director |
| Mr. Guillaume Leger | Group Chief Financial Officer |
| Mr. Clive Norman Bowman | Global Chief Investment Officer |
| Ms. Melanie Buffier | Global Head of Investor Relations |
| Mr. Christopher J. Young | Gen. Counsel of North America |
| Ms. Siobhan Hannon | Global Head of Compliance & Risk |
| Ms. Lindsay Hamilton | Global Chief Marketing Officer |
| Ms. Tania Sulan | Managing Director of Transformation |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.3181 |
| Price-to-Sales TTM: | 34.4611 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 199 |